Wednesday, March 27, 2019

Strides Pharma gets USFDA nod for Singapore facility

Strides Pharma gets USFDA nod for Singapore facility With the commercialisation of this facility, the company will join the league of global pharmaceutical companies having manufacturing and research and development footprint in Singapore.

from Moneycontrol Business News https://ift.tt/2YslIQF

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...